WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Pharmaceutical sourcing from non-Trade Agreement Act countries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW B HOEKSTRA | — |
| GEORGE OLSEN | — |
| ANTHONY J RODA | Leadership Staff, House Whip Gingrich |
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry, tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES New | LA and LD, Rep. Bud Cramer |
| CHRISTOPHER W HATCHER | — |
| TESS ILLOS | — |
| GEORGE OLSEN | — |
Health Issues HCR
Implementation of Patient Protection and Affordable Care Act. Drug safety and drug counterfeiting. (track and trace)Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES New | LA and LD, Rep. Bud Cramer |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
| ANTHONY J RODA | Leadership Staff, House Whip Gingrich |
Medicare/Medicaid MMM
Medicare prescription drug benefit; drug rebates for Medicare Part D. Indpendent Payment Advisory Board (IPAB). House and Senate Budget resolutions; Continuing Resolution Appropriations for FY 2013 (H.R. 933)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES New | LA and LD, Rep. Bud Cramer |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTRAZENECA PLC | United Kingdom | United Kingdom | 100.0% | — |
| ASTRAZENECA UK LIMITED | United Kingdom | United Kingdom | 100.0% | — |
| ASTRAZENECA AB | Sweden | Sweden | 90.3% | — |
| ASTRAZENECA TREASURY LIMITED | United Kingdom | United Kingdom | 100.0% | — |
| ASTRAZENECA INTERMEDIATE HOLDINGS LTD. | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.